Solutions
Investment Management

Institutional Investors

Individual Investors

Corporations

Competitive Intelligence

Investor Relations

SEC Reporting

Corporate Strategy
Product
Document Search

Data Analysis

Equity Data Terminal

Research Management

Notetaking and Collaboration

Security and Availability

Data & Documents

Content Sources
Learn
Why Sentieo

Resources

Customers

Events

Blog
Contact Us
Login
Free Trial

On-Demand Webinar

Sentieo and JUST Capital: Corporate COVID-19 Response and Stakeholder-driven Leadership

Join Sentieo's Head of Research, Nick Mazing, and JUST Capital's Director, Metrics & Data Analytics, Sam Schrager for ESG perspectives on corporate COVID-19 response and stakeholder-driven leadership during a pandemic.

Sign up by filling out the form to the right.

Register here

Resources

AI-Driven Insights: Q3 2020 Earnings

Office REITs Hurt by Slow Return to the Office

We have been tracking the “return to the office” trends across filings, transcripts, and macro data since the summer. The fundamentals have not changed: things will not be back to the “old normal” nor will they be near the “new normal” until schools and after-schools are fully open, regardless of vaccine developments.

Vaccine Comments Across Industries

With the great news from Pfizer and BioNTech regarding their COVID vaccine development on Monday, November 9, 2020, we observed major rotations in the equity markets. For example, several of the “Work From Home” names that we wrote about in February, well ahead of the March sell-off, were down double-digits on the news, including Zoom, Teladoc, and Peloton.